5.1 Neoplasm Table, Primary, Secondary & Encounters for Therapy

AHIMA Certified Coding Specialist CCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: ICD-10-CM Diagnosis Coding Fundamentals & UHDDS Guidelines

1.1 ICD-10-CM Structure, Formats, and Core Conventions 1.2 UHDDS Principal Diagnosis Selection Rules 1.3 Secondary Diagnoses Reporting & Present on Admission (POA) Indicators

2 Chapter 2: Circulatory, Cardiac & Vascular Inpatient Coding

2.1 Hypertension, Hypertensive Heart & Chronic Kidney Disease, and CAD 2.2 Acute Myocardial Infarction (AMI) Types & Sequencing 2.3 Heart Failure Types, Acuity & Cardiomyopathy 2.4 Cerebrovascular Disease, Acute Stroke, and Late Effects

3 Chapter 3: Respiratory, Sepsis & Infectious Conditions Coding

3.1 Sepsis, Severe Sepsis, and Septic Shock Guidelines 3.2 Pneumonias, Aspiration Pneumonia, and Influenza 3.3 COPD, Asthma, and Acute Respiratory Failure

4 Chapter 4: Renal, Endocrine, Gastrointestinal & Nutritional Disorders

4.1 Acute Kidney Injury (AKI) & Chronic Kidney Disease (CKD) 4.2 Diabetes Mellitus Types, Manifestations & Complications 4.3 Protein-Calorie Malnutrition & Endocrine Emergencies 4.4 Gastrointestinal Bleeding, Ulcers, and Acute Abdominal Pathologies

5 Chapter 5: Neoplasms, Obstetrics, Perinatal, Injury & Trauma Coding

5.1 Neoplasm Table, Primary, Secondary & Encounters for Therapy 5.2 Obstetrics, Normal/Complicated Deliveries & Puerperium 5.3 Perinatal Conditions & Congenital Malformations 5.4 Traumatic Injuries, Fractures & 7th Character Extensions

6 Chapter 6: ICD-10-PCS Architecture, Conventions & Approaches

6.1 ICD-10-PCS 7-Character System Architecture & Conventions 6.2 ICD-10-PCS The Seven Surgical Approaches 6.3 General PCS Guidelines & Multiple Procedure Rules

7 Chapter 7: ICD-10-PCS Root Operations: Cutting Out, Taking Out & Altering Body Parts

7.1 Excision vs Resection vs Destruction 7.2 Extraction, Drainage, and Extirpation 7.3 Detachment & Amputation Coding 7.4 Release vs Division

8 Chapter 8: ICD-10-PCS Root Operations: Putting In, Putting Back & Moving Body Parts

8.1 Replacement vs Supplement vs Insertion 8.2 Reposition, Transfer, and Reattachment 8.3 Bypass, Dilation, Occlusion, and Restriction

9 Chapter 9: High-Volume Inpatient Surgical & Medical Procedures in ICD-10-PCS

9.1 Coronary Artery Bypass Grafting (CABG) & Percutaneous Coronary Interventions 9.2 Total Joint Arthroplasties & Spinal Fusion 9.3 Mechanical Ventilation & Extracorporeal Therapies

10 Chapter 10: Outpatient CPT & HCPCS Level II Coding & Modifiers

10.1 CPT Evaluation and Management (E/M) Guidelines 10.2 CPT Surgical, Radiology, Pathology & HCPCS Level II Coding 10.3 CPT Modifiers in Hospital Outpatient & Professional Coding

11 Chapter 11: Inpatient Record Review, Clinical Validation & Documentation Integrity

11.1 Inpatient Health Record Analysis & UHDDS Documentation Hierarchy 11.2 Clinical Validation of Diagnoses vs Coding Compliance 11.3 Identifying Reportable Secondary Conditions & Complications

12 Chapter 12: Compliant Provider Queries & AHIMA/ACDIS Standards

12.1 AHIMA/ACDIS Compliant Query Standards & Ethical Principles 12.2 Compliant Query Formats: Open-Ended, Multiple-Choice & Yes/No 12.3 High-Impact Clinical Query Scenarios & Provider Workflow

13 Chapter 13: Inpatient Prospective Payment System (IPPS) & MS-DRG Mechanics

13.1 IPPS Reimbursement Structure & MS-DRG Grouping Logic 13.2 Complications and Comorbidities (CC) & Major CC (MCC) Impact 13.3 All-Patient Refined DRG (APR-DRG) System 13.4 Inpatient Transfer Policies, Cost Outliers & Short-Stay Rules

14 Chapter 14: Outpatient Reimbursement, Coding Edits & Fraud/Abuse Compliance

14.1 Hospital Outpatient Prospective Payment System (OPPS) & APCs 14.2 National Correct Coding Initiative (NCCI) Edits & MUEs 14.3 Hospital-Acquired Conditions (HAC) Reduction & Quality Programs 14.4 Healthcare Fraud, Abuse Laws, Audits & AHIMA Ethical Standards

15 Chapter 15: Health Information Technology, CAC, Encoders & Data Security

15.1 Electronic Health Records (EHR) & Computer-Assisted Coding (CAC) 15.2 Logic-Based Encoders, Groupers & Health Data Systems 15.3 HIPAA Privacy/Security, Cybersecurity & Internal Coding Audits

5.1 Neoplasm Table, Primary, Secondary & Encounters for Therapy

Key Takeaways Explain This Topic AI

The ICD-10-CM Neoplasm Table organizes neoplasms across six clinical behavior axes: Malignant Primary, Malignant Secondary, Ca In Situ, Benign, Uncertain Behavior, and Unspecified Behavior.

When an encounter is solely for the administration of chemotherapy (Z51.11), immunotherapy (Z51.12), or radiation therapy (Z51.0), the Z-code is sequenced as the principal diagnosis, followed by the active malignancy.

Admissions for antineoplastic treatment complications follow strict sequencing: dehydration is sequenced first (E86.0), whereas anemia induced by antineoplastic therapy requires the anemia code (D64.81) first, followed by the malignancy and adverse effect code (T45.1X5A).

A personal history code (Z85.x) is reported only when the primary malignancy has been completely excised or eradicated, with no remaining tumor, no recurrence, and no ongoing primary-directed treatment.

Last updated: August 2026

Neoplasms, Oncology Coding & Therapeutic Sequencing

AHIMA CCS Exam Focus: Oncology coding represents one of the most critical and complex clinical domains on the Certified Coding Specialist (CCS) examination. Inpatient coders must master the six behavioral columns of the ICD-10-CM Neoplasm Table, adhere strictly to the sequencing hierarchies outlined in ICD-10-CM Official Guidelines for Coding and Reporting (Section I.C.2), differentiate between active malignancy and personal history (Z85.x), correctly sequence encounters solely for antineoplastic therapy (Z51.xx), and accurately code treatment-related toxicities versus malignancy-related complications.

1. Architecture of the ICD-10-CM Neoplasm Table

To code neoplasms accurately, the coder must understand both the anatomical site and the biological behavior of the tumor. The ICD-10-CM Neoplasm Table is indexed alphabetically by anatomical site (e.g., breast, lung, colon) and structured into six distinct behavioral columns :

Neoplasm Table Column ICD-10-CM Categories Pathological & Clinical Definition

1. Malignant Primary C00 – C75 , C76 – C96 Autonomous, invasive neoplasm that originates at the specified anatomical site, characterized by uncontrolled cellular proliferation and stromal invasion.

2. Malignant Secondary C77 – C79 Metastatic lesion; tumor cells that have spread from a distant primary anatomical origin via hematogenous, lymphatic, or direct seeding pathways.

3. Carcinoma in Situ D00 – D09 Non-invasive, pre-malignant neoplastic proliferation confined within the epithelial basement membrane without invasion into the underlying stroma.

4. Benign D10 – D36 Non-cancerous, non-invasive, localized tumor composed of well-differentiated mature cells that do not metastasize or invade adjacent tissue.

5. Uncertain Behavior D37 – D48 Microscopic histology is pathologically indeterminate; the pathologist cannot establish whether the lesion is benign or malignant at the cellular level.

6. Unspecified Behavior D49 Assigned when the medical record lacks histological characterization (e.g., clinical diagnosis of 'mass', 'growth', or 'tumor' without a completed pathology report). NEOPLASM TABLE LOOKUP WORKFLOW

│
[Identify Anatomical Site]
│
┌─────────────────────────────────┴─────────────────────────────────┐
▼ ▼
[Pathology Report Available] [No Pathology / Pending]
│ │
┌────────────┴────────────┐ ▼
▼ ▼ [Unspecified Behavior (D49)]
[Invasive Malignancy] [Non-Invasive / Benign]
│ │
├─► Primary (C00-C76) ├─► In Situ (D00-D09)
└─► Secondary (C77-C79) ├─► Benign (D10-D36)
└─► Uncertain Behavior (D37-D48)
Alphabetic Index vs. Neoplasm Table Entry Rules

Morphology First: If the diagnostic statement specifies a histological term (e.g., adenocarcinoma, osteosarcoma, melanoma, lymphoma, leukemia ), the coder must first consult the Alphabetic Index under the specific morphological term.

Cross-References: The Alphabetic Index will direct the coder either to a specific code (e.g., Melanoma of trunk C43.59 , Multiple myeloma C90.00 ) or to the Neoplasm Table for site-specific selection.

Contiguous / Overlapping Sites: A primary malignant neoplasm that overlaps two or more contiguous sites within the same three-character category is classified to the subcategory .8 ( overlapping lesion ), unless a specific combination code exists.

2. Sequencing Hierarchy: Primary vs. Secondary Malignancies (Section I.C.2.a–d)

The Uniform Hospital Discharge Data Set (UHDDS) definition of principal diagnosis governs oncology sequencing based on the clinical reason established after study for the acute inpatient admission.

Scenario A: Admission for Treatment of Primary Site

When an inpatient admission is directed primarily toward the surgical resection, ablation, or local therapy of the primary malignancy , the primary site code ( C00 – C76 ) is sequenced as the Principal Diagnosis . Any documented secondary (metastatic) sites are reported as secondary diagnoses.

Scenario B: Admission for Treatment of Secondary / Metastatic Site Solely

When an admission is directed solely toward the management or treatment of a metastatic site (e.g., stereotactic radiosurgery for brain metastases, spinal cord decompression for metastatic vertebral lesions), the secondary malignancy code ( C77 – C79 ) is sequenced as the Principal Diagnosis . The primary malignancy is reported as an additional secondary diagnosis if still active.

Scenario C: Primary Site Previously Eradicated with Active Metastasis

When the primary malignancy has been surgically resected or eradicated with no evidence of primary site recurrence, but the patient presents for treatment of a metastatic site:

Principal Diagnosis: Secondary (metastatic) malignancy code ( C77 – C79 ).

Secondary Diagnosis: Personal history of malignant neoplasm ( Z85.x ) representing the original primary site. Example: Inpatient admission for hepatic resection of metastatic colon adenocarcinoma;

primary sigmoid colon cancer was resected 2 years ago without local recurrence.

Principal Diagnosis: C78.7 (Secondary malignant neoplasm of liver)
Secondary Diagnosis: Z85.038 (Personal history of other malignant neoplasm of large intestine)
Scenario D: Multiple Primary Malignancies

When a patient presents with multiple independent primary sites (e.g., synchronous primary breast cancer and primary endometrial cancer) and treatment is directed equally at both during the same encounter, either primary malignancy may be sequenced first , followed by the other.

3. Encounters for Antineoplastic Therapy (Section I.C.2.e)

When a patient is admitted to an acute inpatient facility or presents to an outpatient oncology clinic solely for the administration of antineoplastic chemotherapy, immunotherapy, or radiation therapy , official coding guidelines mandate specific Z-code sequencing. ADMISSION SOLELY FOR ANTINEOPLASTIC THERAPY

│
┌────────────────────────────────┼────────────────────────────────┐
▼ ▼ ▼
[Chemotherapy] [Immunotherapy] [Radiation Therapy]
(Z51.11) (Z51.12) (Z51.0)
│ │ │
└────────────────────────────────┬────────────────────────────────┘
▼
[Principal Diagnosis: Z-Code]
│
▼
[Secondary Diagnosis: Active Malignancy Code]
Key Rules for Therapeutic Z-Codes

Sole Reason for Encounter: Code Z51.11 ( Encounter for antineoplastic chemotherapy ), Z51.12 ( Encounter for antineoplastic immunotherapy ), or Z51.0 ( Encounter for antineoplastic radiation therapy ) is sequenced as the Principal / First-Listed Diagnosis .

Secondary Code: The active malignancy (primary or secondary) being treated is reported as the secondary diagnosis. Even if the primary tumor was resected and the patient is receiving adjuvant therapy to prevent recurrence, code the active malignancy code ( C-code ), not a history code ( Z85.x ).

Multiple Modalities: If a patient receives both chemotherapy and radiation therapy during the same admission, code Z51.0 and Z51.11 may both be reported; sequence the modality that occasioned the inpatient admission first.

Complication Developing During Therapy Stay: If a patient is admitted solely for chemotherapy ( Z51.11 ) and develops an unexpected complication during the stay (e.g., severe nausea, acute vomiting, or dehydration), Z51.11 remains the Principal Diagnosis , with the complications coded as secondary conditions.

4. Sequencing Complications of Malignancy and Antineoplastic Therapy

One of the highest-yield testing areas on the AHIMA CCS exam is determining principal diagnosis when a patient is admitted with acute clinical complications related to cancer or its treatment.

Matrix of Oncology Complication Sequencing

Clinical Presentation Principal Diagnosis Secondary Diagnoses Official Guideline Rule

Anemia due to Antineoplastic Chemotherapy / Radiation D64.81 ( Other antineoplastic chemotherapy induced anemia ) 1. Malignancy code ( C00 – C96 ); 2. T45.1X5A ( Adverse effect of antineoplastic drugs, initial encounter ) Admitted specifically for treatment of drug-induced anemia; D64.81 sequenced first.

Anemia Associated with Malignancy (Anemia of Chronic Disease) Malignancy code ( C00 – C96 ) D63.0 ( Anemia in neoplastic disease ) Admitted for anemia associated with the cancer itself; malignancy is sequenced first.

Dehydration due to Malignancy or Therapy E86.0 ( Dehydration ) 1. Malignancy code ( C00 – C96 ); 2. Adverse effect code ( T45.1X5A if chemo-induced) When admission is solely for management of dehydration (IV hydration), E86.0 is PDX.

Neutropenic Fever due to Chemotherapy D70.1 ( Agranulocytosis secondary to cancer chemotherapy ) or D70.9 1. R50.81 ( Fever presenting with conditions classified elsewhere ); 2. T45.1X5A ; 3. Malignancy code Neutropenia sequenced first, followed by fever code, adverse effect, and active cancer.

Surgical / Mechanical Complications Complication code (e.g., T81.4- Infection following procedure ) Malignancy code Postoperative infection or mechanical complication is principal diagnosis.

Critical Inpatient Distinction: Notice the fundamental contrast between chemotherapy-induced anemia (where D64.81 is Principal Diagnosis) and anemia of neoplastic disease (where the Malignancy is Principal Diagnosis and D63.0 is secondary). Confusing these two scenarios is a frequent pitfall on the CCS exam.

5. Pathological Fractures in Neoplastic Disease (Section I.C.2.m)

A pathological fracture occurs in a bone weakened by an underlying disease process (such as primary bone cancer or osteolytic metastatic bone disease) under physiological stress or minimal trauma. ADMISSION FOR TREATMENT OF PATHOLOGICAL FRACTURE

│
▼
[Principal Diagnosis: M84.5- Category Code]
(Pathological fracture in neoplastic disease)
(Requires 7th character for encounter/healing)
│
▼
[Secondary Diagnosis: Malignancy Code]
C79.51 (Secondary malignant neoplasm of bone)
Primary Malignancy Code (e.g., C50.911 Breast)

Sequencing Mandate: When an encounter is for the acute management, surgical fixation, or reduction of a pathological fracture due to a neoplasm, code from subcategory M84.5 ( Pathological fracture in neoplastic disease ) is sequenced as the Principal Diagnosis .

Required 7th Character: The M84.5- code requires a 7th character extension indicating the encounter type and healing phase ( A for initial encounter, D for subsequent encounter with routine healing, K for nonunion, P for malunion, S for sequela).

Secondary Neoplasm Assignment: Sequence the secondary bone neoplasm ( C79.51 ) and the primary neoplasm (or Z85.x history code if primary was eradicated) as secondary diagnoses.

Traumatic vs. Pathologic: Never assign a traumatic fracture code ( S-category ) for a fracture occurring through a bone site compromised by metastatic tumor.